The antidepressant-like effect of vagus nerve stimulation is mediated through the locus coeruleus
Introduction
Major depressive disorders are highly prevalent, widely distributed in the population and usually associated with substantial symptom severity and role impairment (Kessler et al., 2003). While depressive symptoms can be effectively treated with antidepressant drugs or psychotherapy in the majority of patients, up to 20% of patients fail to respond to standard interventions (Fava, 2003). These drug-refractory patients are candidates for treatment with neurostimulation therapies such as vagus nerve stimulation (VNS).
VNS is an extracranial neurostimulation technique, where the cervical region of the left vagus nerve is stimulated by means of a helical electrode, connected to a subclavicularly-implanted pulse generator. It is a well-established, safe and effective add-on therapy for refractory epilepsy (Ben-Menachem, 2002). The initial rationale for using VNS for the treatment of refractory depression was based on mood improvements observed in epilepsy patients treated with VNS, irrespective of the effects of VNS on seizure frequency (Elger et al., 2000, Harden, 2002). Several clinical studies have subsequently confirmed the therapeutic efficacy of VNS for treatment resistant depression (Rush et al., 2000, Rush et al., 2005a, Rush et al., 2005b, Sackeim et al., 2001, Marangell et al., 2002, George et al., 2005, Nahas et al., 2005, Schlaepfer et al., 2008, Bajbouj et al., 2010, Cristancho et al., 2011), but the mechanism of action is still unknown.
The forced swim test is one of the most commonly used and validated experimental assays to assess depression-like behavior in rodents. During the test, animals are placed in a cylinder filled with water from which they cannot escape. Mobile escape-related behavior (defined as forepaw movements along the side of the cylinder and swimming throughout the cylinder) and immobile passive behavior (defined as the lack of whole body movement, except for small efforts to keep the head above water) are scored blindly on videotaped images of the test. A reduction in immobile passive behavior is reflective of an antidepressant-like effect of the investigated intervention (Porsolt et al., 1977, Slattery and Cryan, 2012). To rule out the possibility that the effects in the forced swim test are caused by an overall change in locomotor activity, an open field test can be performed. Krahl et al. showed that VNS produces an antidepressant-like effect in the forced swim test in rats with the same efficacy as electroconvulsive shock therapy and the tricyclic antidepressant desipramine (Krahl et al., 2004).
Since the 1960s there has been a strong emphasis on the role of noradrenaline both in the pathogenesis of depressive disorders and in the mechanism of action of antidepressants (Schildkraut, 1965, Moret and Briley, 2011). This largely results from the fact that many of the first generation antidepressants, the tricyclics, increase the synaptic concentration of noradrenaline (Cryan et al., 2002). There is extensive evidence demonstrating that VNS also enhances the noradrenergic neurotransmission through the activation of the locus coeruleus (LC) (Florin-Lechner et al., 1996, Hassert et al., 2004, Groves et al., 2005, Dorr and Debonnel, 2006, Roosevelt et al., 2006, Follesa et al., 2007, Manta et al., 2009, Manta et al., 2012b, Raedt et al., 2011), which is the main source of cortical noradrenaline (Krahl and Clark, 2012). Therefore, we investigated the hypothesis that the VNS-induced antidepressant-like effect in the forced swim test is mediated through activation of the LC and subsequent release of noradrenaline. For this purpose LC neurons were lesioned using DSP-4 [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride], a highly selective neurotoxin for the noradrenergic axons originating from the LC (Fritschy and Grzanna, 1989, Fritschy and Grzanna, 1991).
Section snippets
Methods and materials
A schematic overview of the study design is shown in Fig. 1. All procedures are described in detail below.
Forced swim test and open field test
The fraction of immobility in the forced swim test was significantly lower in the VNS group (median: 56%, interquartile range: 41%) compared to the sham group (median: 75%, interquartile range: 12%) (p < 0.05). This antidepressant-like effect of VNS was abolished in the DSP-4-VNS group (median: 79%, interquartile range: 33%), reflected by a level of immobility similar to the sham group (p > 0.05) and significantly higher than the VNS group (p < 0.05) (see Fig. 2A).
There were no significant
Discussion
In this study, we demonstrated that VNS has an antidepressant-like effect based on a significant reduction of the immobility time in the forced swim test. These findings are congruent with the results of a previous study by Krahl et al. (2004). In the present study, the antidepressant-like effect of VNS was completely abolished when the noradrenergic neurons arising from the LC were eliminated using the selective noradrenergic neurotoxin DSP-4. To rule out the possibility that the effects in
Contributors
Annelies Grimonprez conducted the experiments, did the analysis of the data and wrote the first draft of the manuscript. Charlotte Bouckaert was the second blinded investigator for the analysis of the behavioral tests. Annelies Grimonprez, Prof. Dr. Robrecht Raedt, Dr. Jeanelle Portelli, Ine Dauwe, Lars Emil Larsen, Prof. Dr. Alfred Meurs, Prof. Dr. Jean Delbeke, Dr. Evelien Carrette, Prof. Dr. Veerle De Herdt, Prof. Dr. Paul Boon and Prof. Dr. Kristl Vonck contributed to the design of the
Role of the funding source
This study was supported by the Laboratory for Clinical and Experimental Neurophysiology, Neurobiology and Neuropharmacology (LCEN3), which is a subdivision of the Institute for Neuroscience of Ghent University Hospital. Furthermore, Prof. Dr. Robrecht Raedt and Prof. Dr. Kristl Vonck are supported by a grant from the “Bijzonder Onderzoeksfond (BOF)” from Ghent University.
Conflict of interest
None.
Acknowledgments
Annelies Grimonprez is supported by a PhD-grant from Ghent Institute for Neuroscience. Prof. Dr. Robrecht Raedt and Prof. Dr. Kristl Vonck are supported by a grant from the “ Bijzonder Onderzoeksfond (BOF) ” from Ghent University. Prof. Dr. Paul Boon is supported by grants from FWO, grants from BOF and by the Clinical Epilepsy Grant from Ghent University Hospital.
References (73)
Vagus-nerve stimulation for the treatment of epilepsy
Lancet Neurol
(2002)- et al.
Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients
Biol Psychiatry
(2004) - et al.
Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test
Eur J Pharmacol
(2002) - et al.
Regulation of adult neurogenesis by antidepressant treatment
Neuropsychopharmacology
(2001) - et al.
Vagus nerve stimulation is associated with mood improvements in epilepsy patients
Epilepsy Res
(2000) Diagnosis and definition of treatment-resistant depression
Biol Psychiatry
(2003)- et al.
Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus
Brain Res
(1996) - et al.
Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain
Brain Res
(2007) - et al.
Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals
Neuroscience
(1989) - et al.
Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
Prog Brain Res
(1991)